The development of JAFS, a new computational method to study the binding geometries of small fragment molecules to protein cavities, estimate their binding affinities and analyse how they compete for a common protein binding site, all in the context of Fragment Based Drug Discovery, is presented in this thesis.Fragment Based Drug Discovery is an approach to drug development which studies the binding of small ligands (fragments) forming high quality interactions with their target. Further optimization of these fragments into drug-like molecules, adding functionalities to increase affinity while controlling other relevant properties such as toxicity and absorption then takes place. JAFS studies the binding of fragments to their target protein...
Computer simulations of biomolecules have been improving at a pace that is faster than Moore’s law ...
The rationalisation of drug potency using three-dimensional structures of protein-ligand complexes i...
Thesis (Ph.D.)--Boston UniversityPLEASE NOTE: Boston University Libraries did not receive an Authori...
Predicting the costructure of small-molecule ligands and their respective target proteins has been a...
<div><p>Target-based drug discovery must assess many drug-like compounds for potential activity. Foc...
Fragment-Based Drug Discovery (FBDD) approaches have gained popularitynot only in industry but also ...
Fragment-based strategy in drug design involves the initial discovery of low-molecular mass molecule...
Fragment-based lead discovery is becoming an increasingly popular strategy for drug discovery. Fragm...
A novel crystallographic fragment screening data set was generated and used in the SAMPL7 challenge ...
Diverse computational methods to support Fragment-based drug discovery (FBDD) are available in the l...
Fragment-based drug discovery (FBDD) has been popular in the last decade, but some drawbacks, such a...
Locating a ligand-binding site is an important first step in structure-guided drug discovery, but cu...
Fragment-based drug discovery typically requires an interplay between screening methods, structural ...
Protein-protein interactions (PPIs) have emerged in the past years as significant pharmacological ta...
Funder: ExscientiaFunder: Diamond Light SourceFunder: Kungliga Tekniska HoegskolanFunder: Chinese Ce...
Computer simulations of biomolecules have been improving at a pace that is faster than Moore’s law ...
The rationalisation of drug potency using three-dimensional structures of protein-ligand complexes i...
Thesis (Ph.D.)--Boston UniversityPLEASE NOTE: Boston University Libraries did not receive an Authori...
Predicting the costructure of small-molecule ligands and their respective target proteins has been a...
<div><p>Target-based drug discovery must assess many drug-like compounds for potential activity. Foc...
Fragment-Based Drug Discovery (FBDD) approaches have gained popularitynot only in industry but also ...
Fragment-based strategy in drug design involves the initial discovery of low-molecular mass molecule...
Fragment-based lead discovery is becoming an increasingly popular strategy for drug discovery. Fragm...
A novel crystallographic fragment screening data set was generated and used in the SAMPL7 challenge ...
Diverse computational methods to support Fragment-based drug discovery (FBDD) are available in the l...
Fragment-based drug discovery (FBDD) has been popular in the last decade, but some drawbacks, such a...
Locating a ligand-binding site is an important first step in structure-guided drug discovery, but cu...
Fragment-based drug discovery typically requires an interplay between screening methods, structural ...
Protein-protein interactions (PPIs) have emerged in the past years as significant pharmacological ta...
Funder: ExscientiaFunder: Diamond Light SourceFunder: Kungliga Tekniska HoegskolanFunder: Chinese Ce...
Computer simulations of biomolecules have been improving at a pace that is faster than Moore’s law ...
The rationalisation of drug potency using three-dimensional structures of protein-ligand complexes i...
Thesis (Ph.D.)--Boston UniversityPLEASE NOTE: Boston University Libraries did not receive an Authori...